Search

Search Results

• Aldosterone synthase inhibitors in cardio-renal diseases: a state-of-the-art review

  Muhammad Hamza Dawood, Muhammad Shahzeb Khan, Ahmed Mustafa Rashid, Wilhelm Haverkamp

  2025-12-31

  https://doi.org/10.4081/cardio.2025.91

  1151

  PDF: 784

  HTML: 157

• 2026 iCARDIO Alliance Global Implementation Guidelines on Heart Failure

  Vijay Chopra, William T. Abraham, Offer Amir, Stefan D. Anker, John J. Atherton, Fernando Bacal, Ralph Stephan von Bardeleben , Dulce Brito, Lucrecia Maria Burgos, Javed Butler, Maria Rosa Costanzo, Albertino Damasceno, Justin A. Ezekowitz, Ishaque Hameed, Sivadasanpillai Harikrishnan, Anuradha Lala, Ileana L. Piña, Clara Saldarriaga, David Sim, John R. Teerlink, Nqoba Tsabedze, Hiroyuki Tsutsui, Jing Yu, Yuhui Zhang, Mohammad Zubaid, Nikhil Balankhe, John G.F. Cleland, Gemma Figtree, Gerasimos Filippatos, Marat Fudim, Habib Gamra, Juan Esteban Gomez-Mesa, Martha Gulati, James L. Januzzi, Marvin A. Konstam, JoAnn Lindenfeld, Robert J. Mentz, Rhonda Monroe, Elijah Ogola, Fausto J. Pinto, Girish C. Rajadhyaksha, Carlos E. Ramos, Giuseppe Rosano, Victor Rossel, Naoki Sato, P. Christian Schulze, Andrew Sindone, Kadhim Sulaiman, Muthiah Vaduganathan, Harriette G.C. Van Spall, Dirk J. van Veldhuisen, Stephan von Haehling, Tzung-Dau Wang, Pepe Zamorano, Michael Böhm, Andrew J.S. Coats, Shelley Zieroth

  2026-08-24

  https://doi.org/10.4081/cardio.2026.117

  2971

  PDF: 1611

  APPENDIX: 145

  HTML: 28

• The scientific targets: the myocardium, the vasculature and the body’s response to heart failure

  Rafael Vidal-Pérez, Ewa A. Jankowska

  2024-03-28

  https://doi.org/10.4081/cardio.2024.19

  3101

  PDF: 487

  HTML: 68

• Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction

  Christian Basile, Stefan D. Anker, Gianluigi Savarese

  2025-07-16

  https://doi.org/10.4081/cardio.2025.76

  1083

  PDF: 439

  Supplementary: 240

  Appendix: 263

  HTML: 78

• Mineralocorticoid receptor antagonists in heart failure with preserved (and mildly reduced) ejection fraction: a comparative review of spironolactone and finerenone

  Hafsa Azam, Syed Sarmad Javaid, Mahir Karakas

  2026-07-06

  https://doi.org/10.4081/cardio.2026.110

  423

  PDF: 234

  HTML: 36

• Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction

  Christian Basile, Stefan D. Anker, Gianluigi Savarese

  2025-06-30

  https://doi.org/10.4081/cardio.2025.73

  1220

  PDF: 479

  Supplementary: 278

  Appendix: 210

  HTML: 161

• Obesity and left atrial function: state of the art

  Ahmed Mustafa Rashid, Muhammad Shahzeb Khan, Fawaz Alenezi, Stefan D. Anker, Fabian Knebel

  2026-03-31

  https://doi.org/10.4081/cardio.2026.96

  1169

  PDF: 422

  HTML: 181

• Neck-to-height ratio in Bosnian university students according to the 2017 American College of Cardiology/American Heart Association guidelines on hypertension classification

  Asija Začiragić, Marija Mikić, Amela Dervišević, Orhan Lepara, Nesina Avdagić, Nermina Babić, Almir Fajkić, Amina Valjevac

  2024-03-28

  https://doi.org/10.4081/cardio.2024.27

  2285

  PDF: 552

  HTML: 22

• Beyond trial neutrality: treatment discontinuation and the hidden signal in SPIRIT-HF trial

  Viana Copeland, Andrew J.S. Coats

  2026-03-31

  https://doi.org/10.4081/cardio.2026.100

  1586

  PDF: 472

  HTML: 284

• Optimized heart failure therapy in patients with very advanced cancer in palliative care: dosing strategies from the EMPATICC trial

  Markus S. Anker, Sven Bercker, Ulrich Laufs, Michael Böhm, Bela Merkely, Monika Diek, Tim Heise, Martin Hellmich, Marius Placzek, Tim Friede, Stefan D. Anker, Lorenz Lehmann, Ulf Landmesser, Dominik P. Modest, Muhammad Shahzeb Khan, Amir A. Mahabadi, Matthias Totzeck, Mitra Tewes, Muhammad Sameer Arshad, Raluca Mincu, Javed Butler, Ulrich Keller, Johann Ahn, Lars Bullinger, Tienush Rassaf

  2025-08-20

  https://doi.org/10.4081/cardio.2025.78

  900

  PDF: 595

  Appendix: 324

  HTML: 95

• Effect of metformin and empagliflozin on myocardial function in insulin-resistant patients with heart failure: rationale and design of the METRIS-HF-DZHK18 Trial

  Wolfram Doehner, Tim Friede, Frank Edelmann, Ulf Landmesser, Sebastian Winkler, Burkert Pieske, Fabian Knebel, Sebastian Kelle, Diethelm Tschöpe, Antje Meyer, Nadja Jauert, Marius Placzek, Jeanette Schulz-Menger, Stephan von Haehling, Stefan D. Anker

  2025-12-31

  https://doi.org/10.4081/cardio.2025.89

  592

  PDF: 511

  Appendix: 97

  HTML: 24

• Evolving targets for heart failure: the journey so far

  Giuseppe M.C. Rosano, Jerneja Farkas

  2023-11-28

  https://doi.org/10.4081/cardio.2023.6

  2557

  pdf: 568

  HTML: 4

• What is new and what has changed in the 2026 Global Heart Failure Implementation Guidelines and why

  Vijay Chopra, William T. Abraham, Offer Amir, Stefan D. Anker, John J. Atherton, Fernando Bacal, Ralph Stephan von Bardeleben, Dulce Brito, Lucrecia Maria Burgos, Javed Butler, Maria Rosa Costanzo, Albertino Damasceno, Justin A. Ezekowitz, Ishaque Hameed, Sivadasanpillai Harikrishnan, Anuradha Lala, Ileana L. Piña, Clara Saldarriaga, David Sim , John R. Teerlink, Nqoba Tsabedze, Hiroyuki Tsutsui, Jing Yu, Yuhui Zhang, Mohammad Zubaid, Nikhil Balankhe, John G.F. Cleland, Gemma Figtree, Gerasimos Filippatos, Marat Fudim, Habib Gamra, Juan Esteban Gomez-Mesa, Martha Gulati, James L. Januzzi, Marvin A. Konstam, JoAnn Lindenfeld, Robert J. Mentz, Rhonda Monroe, Elijah Ogola, Fausto J. Pinto, Girish C. Rajadhyaksha, Carlos E. Ramos, Giuseppe Rosano, Victor Rossel, Naoki Sato, P. Christian Schulze, Andrew Sindone, Kadhim Sulaiman, Muthiah Vaduganathan, Harriette G.C. Van Spall, Dirk J. van Veldhuisen, Stephan von Haehling, Tzung-Dau Wang, Pepe Zamorano, Michael Böhm, Andrew J.S. Coats, Shelley Zieroth

  2026-08-24

  https://doi.org/10.4081/cardio.2026.118

  913

  PDF: 612

  APPENDIX: 121

  HTML: 31